Figure S2 from Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone Article Swipe
Stefan Maksimovic
,
Nina C. Boscolo
,
Ludovica La Posta
,
Sergio Barrios
,
Mohammad Jad Moussa
,
Emanuela Gentile
,
Pedro I. Pesquera
,
Wenjiao Li
,
Jianfeng Chen
,
Javier A. Gomez
,
Akshay Basi
,
Jared K. Burks
,
Christopher Alvarez‐Breckenridge
,
Jianjun Gao
,
Matthew T. Campbell
,
Eleonora Dondossola
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/2767-9764.28727384
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1158/2767-9764.28727384
Osteoclast recruitment and bone disruption. A) RENCA VHL- cells (green, GFP); osteoclasts (red, TRAP); nuclei (blue, DAPI); white arrowhead, TRAP+ cells. Bar, 50 µm; B) UM-RC-3 (green, GFP); osteoclasts (red, TRAP); nuclei (blue, DAPI); white arrowhead, TRAP+ cells. Bar, 50 µm. Images captured by confocal microscope. TRAP-tartrate-resistant acid phosphatase. White rectangle, (i); magnification.
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/2767-9764.28727384
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4409127944
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4409127944Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/2767-9764.28727384Digital Object Identifier
- Title
-
Figure S2 from Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in BoneWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-04-03Full publication date if available
- Authors
-
Stefan Maksimovic, Nina C. Boscolo, Ludovica La Posta, Sergio Barrios, Mohammad Jad Moussa, Emanuela Gentile, Pedro I. Pesquera, Wenjiao Li, Jianfeng Chen, Javier A. Gomez, Akshay Basi, Jared K. Burks, Christopher Alvarez‐Breckenridge, Jianjun Gao, Matthew T. Campbell, Eleonora DondossolaList of authors in order
- Landing page
-
https://doi.org/10.1158/2767-9764.28727384Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/2767-9764.28727384Direct OA link when available
- Concepts
-
Renal cell carcinoma, Tyrosine kinase, Cancer research, Tyrosine-kinase inhibitor, Medicine, Cell, Internal medicine, Oncology, Chemistry, Biochemistry, Cancer, ReceptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4409127944 |
|---|---|
| doi | https://doi.org/10.1158/2767-9764.28727384 |
| ids.doi | https://doi.org/10.1158/2767-9764.28727384 |
| ids.openalex | https://openalex.org/W4409127944 |
| fwci | 0.0 |
| type | preprint |
| title | Figure S2 from Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10449 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9962999820709229 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2740 |
| topics[0].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[0].display_name | Renal cell carcinoma treatment |
| topics[1].id | https://openalex.org/T12140 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9562000036239624 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Renal and related cancers |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2777472916 |
| concepts[0].level | 2 |
| concepts[0].score | 0.736930787563324 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1164529 |
| concepts[0].display_name | Renal cell carcinoma |
| concepts[1].id | https://openalex.org/C42362537 |
| concepts[1].level | 3 |
| concepts[1].score | 0.6973710060119629 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q87099740 |
| concepts[1].display_name | Tyrosine kinase |
| concepts[2].id | https://openalex.org/C502942594 |
| concepts[2].level | 1 |
| concepts[2].score | 0.5911376476287842 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[2].display_name | Cancer research |
| concepts[3].id | https://openalex.org/C2778820342 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5204120874404907 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q906415 |
| concepts[3].display_name | Tyrosine-kinase inhibitor |
| concepts[4].id | https://openalex.org/C71924100 |
| concepts[4].level | 0 |
| concepts[4].score | 0.49902915954589844 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[4].display_name | Medicine |
| concepts[5].id | https://openalex.org/C1491633281 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4229717254638672 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7868 |
| concepts[5].display_name | Cell |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.3445016145706177 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C143998085 |
| concepts[7].level | 1 |
| concepts[7].score | 0.327751100063324 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[7].display_name | Oncology |
| concepts[8].id | https://openalex.org/C185592680 |
| concepts[8].level | 0 |
| concepts[8].score | 0.28959691524505615 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[8].display_name | Chemistry |
| concepts[9].id | https://openalex.org/C55493867 |
| concepts[9].level | 1 |
| concepts[9].score | 0.14305716753005981 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[9].display_name | Biochemistry |
| concepts[10].id | https://openalex.org/C121608353 |
| concepts[10].level | 2 |
| concepts[10].score | 0.12276259064674377 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[10].display_name | Cancer |
| concepts[11].id | https://openalex.org/C170493617 |
| concepts[11].level | 2 |
| concepts[11].score | 0.05376821756362915 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[11].display_name | Receptor |
| keywords[0].id | https://openalex.org/keywords/renal-cell-carcinoma |
| keywords[0].score | 0.736930787563324 |
| keywords[0].display_name | Renal cell carcinoma |
| keywords[1].id | https://openalex.org/keywords/tyrosine-kinase |
| keywords[1].score | 0.6973710060119629 |
| keywords[1].display_name | Tyrosine kinase |
| keywords[2].id | https://openalex.org/keywords/cancer-research |
| keywords[2].score | 0.5911376476287842 |
| keywords[2].display_name | Cancer research |
| keywords[3].id | https://openalex.org/keywords/tyrosine-kinase-inhibitor |
| keywords[3].score | 0.5204120874404907 |
| keywords[3].display_name | Tyrosine-kinase inhibitor |
| keywords[4].id | https://openalex.org/keywords/medicine |
| keywords[4].score | 0.49902915954589844 |
| keywords[4].display_name | Medicine |
| keywords[5].id | https://openalex.org/keywords/cell |
| keywords[5].score | 0.4229717254638672 |
| keywords[5].display_name | Cell |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.3445016145706177 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/oncology |
| keywords[7].score | 0.327751100063324 |
| keywords[7].display_name | Oncology |
| keywords[8].id | https://openalex.org/keywords/chemistry |
| keywords[8].score | 0.28959691524505615 |
| keywords[8].display_name | Chemistry |
| keywords[9].id | https://openalex.org/keywords/biochemistry |
| keywords[9].score | 0.14305716753005981 |
| keywords[9].display_name | Biochemistry |
| keywords[10].id | https://openalex.org/keywords/cancer |
| keywords[10].score | 0.12276259064674377 |
| keywords[10].display_name | Cancer |
| keywords[11].id | https://openalex.org/keywords/receptor |
| keywords[11].score | 0.05376821756362915 |
| keywords[11].display_name | Receptor |
| language | en |
| locations[0].id | doi:10.1158/2767-9764.28727384 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/2767-9764.28727384 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5032505685 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-7373-082X |
| authorships[0].author.display_name | Stefan Maksimovic |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Stefan Maksimovic |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5094223920 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Nina C. Boscolo |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Nina C. Boscolo |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5107098998 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Ludovica La Posta |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Ludovica La Posta |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5015373743 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0364-2466 |
| authorships[3].author.display_name | Sergio Barrios |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Sergio Barrios |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5102767163 |
| authorships[4].author.orcid | https://orcid.org/0009-0000-7960-8614 |
| authorships[4].author.display_name | Mohammad Jad Moussa |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Mohammad Jad Moussa |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5047804011 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-0332-2385 |
| authorships[5].author.display_name | Emanuela Gentile |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Emanuela Gentile |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5094083050 |
| authorships[6].author.orcid | https://orcid.org/0009-0007-6318-1290 |
| authorships[6].author.display_name | Pedro I. Pesquera |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Pedro I. Pesquera |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5024974543 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-1308-8489 |
| authorships[7].author.display_name | Wenjiao Li |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Wenjiao Li |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5089101481 |
| authorships[8].author.orcid | https://orcid.org/0000-0003-3750-1207 |
| authorships[8].author.display_name | Jianfeng Chen |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Jianfeng Chen |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5069469851 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-6579-744X |
| authorships[9].author.display_name | Javier A. Gomez |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Javier A. Gomez |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5092110230 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Akshay Basi |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Akshay Basi |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5008665039 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-6173-9074 |
| authorships[11].author.display_name | Jared K. Burks |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Jared K. Burks |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5009191269 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5997-6532 |
| authorships[12].author.display_name | Christopher Alvarez‐Breckenridge |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Christopher Alvarez-Breckenridge |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5069915515 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-6138-4472 |
| authorships[13].author.display_name | Jianjun Gao |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Jianjun Gao |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5008861348 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-1915-4491 |
| authorships[14].author.display_name | Matthew T. Campbell |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Matthew T. Campbell |
| authorships[14].is_corresponding | False |
| authorships[15].author.id | https://openalex.org/A5050548999 |
| authorships[15].author.orcid | https://orcid.org/0000-0001-6916-5418 |
| authorships[15].author.display_name | Eleonora Dondossola |
| authorships[15].author_position | last |
| authorships[15].raw_author_name | Eleonora Dondossola |
| authorships[15].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/2767-9764.28727384 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Figure S2 from Antiangiogenic Tyrosine Kinase Inhibitors have Differential Efficacy in Clear Cell Renal Cell Carcinoma in Bone |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10449 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9962999820709229 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2740 |
| primary_topic.subfield.display_name | Pulmonary and Respiratory Medicine |
| primary_topic.display_name | Renal cell carcinoma treatment |
| related_works | https://openalex.org/W4405948659, https://openalex.org/W3025797998, https://openalex.org/W2788319669, https://openalex.org/W2075668427, https://openalex.org/W2046457441, https://openalex.org/W2325158596, https://openalex.org/W2606889348, https://openalex.org/W4240665984, https://openalex.org/W4255244438, https://openalex.org/W1993326728 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/2767-9764.28727384 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/2767-9764.28727384 |
| primary_location.id | doi:10.1158/2767-9764.28727384 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/2767-9764.28727384 |
| publication_date | 2025-04-03 |
| publication_year | 2025 |
| referenced_works_count | 0 |
| abstract_inverted_index.50 | 22, 39 |
| abstract_inverted_index.A) | 5 |
| abstract_inverted_index.B) | 24 |
| abstract_inverted_index.by | 43 |
| abstract_inverted_index.and | 2 |
| abstract_inverted_index.(i); | 51 |
| abstract_inverted_index.Bar, | 21, 38 |
| abstract_inverted_index.VHL- | 7 |
| abstract_inverted_index.acid | 47 |
| abstract_inverted_index.bone | 3 |
| abstract_inverted_index.µm. | 40 |
| abstract_inverted_index.µm; | 23 |
| abstract_inverted_index.(red, | 12, 29 |
| abstract_inverted_index.GFP); | 10, 27 |
| abstract_inverted_index.RENCA | 6 |
| abstract_inverted_index.TRAP+ | 19, 36 |
| abstract_inverted_index.White | 49 |
| abstract_inverted_index.cells | 8 |
| abstract_inverted_index.white | 17, 34 |
| abstract_inverted_index.(blue, | 15, 32 |
| abstract_inverted_index.DAPI); | 16, 33 |
| abstract_inverted_index.Images | 41 |
| abstract_inverted_index.TRAP); | 13, 30 |
| abstract_inverted_index.cells. | 20, 37 |
| abstract_inverted_index.nuclei | 14, 31 |
| abstract_inverted_index.(green, | 9, 26 |
| abstract_inverted_index.UM-RC-3 | 25 |
| abstract_inverted_index.captured | 42 |
| abstract_inverted_index.confocal | 44 |
| abstract_inverted_index.arrowhead, | 18, 35 |
| abstract_inverted_index.rectangle, | 50 |
| abstract_inverted_index.disruption. | 4 |
| abstract_inverted_index.microscope. | 45 |
| abstract_inverted_index.osteoclasts | 11, 28 |
| abstract_inverted_index.recruitment | 1 |
| abstract_inverted_index.phosphatase. | 48 |
| abstract_inverted_index.<p>Osteoclast | 0 |
| abstract_inverted_index.TRAP-tartrate-resistant | 46 |
| abstract_inverted_index.magnification.</p> | 52 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 16 |
| citation_normalized_percentile.value | 0.15979749 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |